低分子創薬市場：治療領域別、プロセス別、エンドユーザー別、地域別

世界の低分子創薬市場は、2025年には610億4,000万米ドルと推定され、2032年には1,102億3,000万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は8.8%で成長すると予測されています。

図.低分子創薬市場シェア（%）、2025年地域別

低分子医薬品には、経口バイオアベイラビリティの高さや組織への浸透性の高さなど、高分子医薬品にはない利点があります。また、経口、静脈内など様々な経路で投与することができます。製薬会社やバイオテクノロジー企業による研究開発活動への投資の増加と、ジェネリック医薬品への需要の高まりが、市場成長の原動力となっています。しかし、臨床検査中の離脱率の高さが市場成長の妨げになる可能性があります。また、複数の新興企業が人工知能や機械学習などの技術を活用して創薬プロセスを強化し、失敗率を低下させています。

市場力学

世界の低分子創薬市場の成長は、製薬研究開発費の増加、ジェネリック医薬品需要の増加、受託研究・製造サービス産業の成長によってもたらされます。しかし、医薬品候補の高い臨床失敗率と厳しい規制が市場成長の妨げになる可能性があります。医薬品開発におけるAIと機械学習の開発の開拓は、市場参入企業に新たな機会を記載しています。製薬会社は、発見プロセスをスピードアップし、分子設計を最適化するために、このような技術を採用するケースが増えています。これにより離職率を低下させることができます。現在、北米が市場を独占しているが、これは大手企業の存在と高い医療支出のためです。近い将来、アジア太平洋が最も急成長する市場になると予想されています。

本調査の主要特徴

本レポートでは、世界の低分子創薬市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の低分子創薬市場の主要企業をプロファイルしています。

主要企業には、Pfizer、ブリストル・マイヤーズスクイブ、メルク、アジレント技術、アストラゼネカ、ベーリンガーインゲルハイム、チャールズリバーラボラトリーズなどが含まれます。

本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

低分子創薬の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業のさまざまな利害関係者を対象としています。

利害関係者は、世界の低分子創薬市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーター分析
• 合併と買収のシナリオ

第4章 世界の低分子創薬市場、治療領域別、2020～2032年（米ドル）

• イントロダクション
• 腫瘍学
• 中枢神経系
• 心臓血管
• 呼吸器
• 代謝障害
• 胃腸
• その他

第5章 世界の低分子創薬市場、プロセス別、2020～2032年（米ドル）

• イントロダクション
• 対象ID/検証
• ヒットの生成と選択
• リード識別
• リード最適化

第6章 世界の低分子創薬市場、エンドユーザー別、2020～2032年（米ドル）

• イントロダクション
• 製薬会社
• バイオテクノロジー企業
• 契約研究機関（CRO）
• 学術研究機関
• その他

第7章 世界の低分子創薬市場、地域別、2020～2032年（米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• AstraZeneca PLC
• GlaxoSmithKline plc
• Bristol Myers Squibb
• Eli Lilly and Company
• Gilead Sciences, Inc.
• Teva Pharmaceuticals
• Boehringer Ingelheim GmbH
• Thermo Fisher Scientific Inc.
• Charles River Laboratories
• Labcorp Drug Development
• Agilent Technologies Inc.
• ICON Plc
• Eurofins Discovery
• Immunocure Inc.
• Acacia Pharma Group
• 4SC AG

第9章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Small Molecule Drug Discovery Market is estimated to be valued at USD 61.04 Bn in 2025 and is expected to reach USD 110.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Small Molecule Drug Discovery Market Share (%), By Region 2025

Small molecule drugs have advantages over large molecule drugs such as higher oral bioavailability and better tissue penetration. These can be administered via various routes including oral, intravenous and others. Growing investment in R&D activities by pharmaceutical and biotech companies coupled with rising demand for generics can drive the market growth. However, high attrition rates during clinical trials can hamper the market growth. Several startups also leverage technologies such as artificial intelligence and machine learning to enhance the drug discovery process and reduce failure rates.

Market Dynamics:

Global small molecule drug discovery market growth is driven by rising pharmaceutical R&D spending, increasing demand for generic drugs, and growth of contract research and manufacturing services industries. However, high clinical failure rates of drug candidates and stringent regulations can hamper the market growth. Growing application of AI and machine learning in drug development offers new opportunities for the market players. Pharma companies are increasingly adopting such technologies to speed up the discovery process and optimize molecular designs. This can lower attrition rates. North America dominates the market currently, owing to presence of major players and high healthcare expenditure. Asia Pacific is anticipated to emerge as the fastest growing market in the near future.

Key features of the study:

This report provides in-depth analysis of the global small molecule drug discovery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global small molecule drug discovery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Bristol-Myers Squibb Company, Merck, Agilent Technologies, AstraZeneca, Boehringer Ingelheim, Charles River Laboratories

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global small molecule drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule drug discovery market

Detailed Segmentation-

• Therapeutic Area Insights (Revenue, USD, 2020 - 2032)
  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Metabolic Disorders
  • Gastrointestinal
  • Others
• Process Insights (Revenue, USD, 2020 - 2032)
  • Target ID/Validation
  • Hit Generation and Selection
  • Lead Identification
  • Lead Optimization
• End User Insights (Revenue, USD, 2020 - 2032)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Teva Pharmaceuticals
  • Boehringer Ingelheim GmbH
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories
  • Labcorp Drug Development
  • Agilent Technologies Inc.
  • ICON Plc
  • Eurofins Discovery
  • Immunocure Inc.
  • Acacia Pharma Group
  • 4SC AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Small Molecule Drug Discovery Market, By Therapeutic Area
  • Global Small Molecule Drug Discovery Market, By Process
  • Global Small Molecule Drug Discovery Market, By End User
  • Global Small Molecule Drug Discovery Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Small Molecule Drug Discovery Market, By Therapeutic Area, 2020-2032, (USD)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Central Nervous System
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Metabolic Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Gastrointestinal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

5. Global Small Molecule Drug Discovery Market, By Process, 2020-2032, (USD)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Target ID/Validation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Hit Generation and Selection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Lead Identification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Lead Optimization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

6. Global Small Molecule Drug Discovery Market, By End User, 2020-2032, (USD)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

7. Global Small Molecule Drug Discovery Market, By Region, 2020 - 2032, (USD)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, (USD)
  • Market Size and Forecast, By Process, 2020 - 2032, (USD)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD)
  • Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Gilead Sciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim GmbH
• Thermo Fisher Scientific Inc.
• Charles River Laboratories
• Labcorp Drug Development
• Agilent Technologies Inc.
• ICON Plc
• Eurofins Discovery
• Immunocure Inc.
• Acacia Pharma Group
• 4SC AG

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us